Maven Securities LTD Satsuma Pharmaceuticals, Inc. Transaction History

Maven Securities LTD

  • $585 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$4.15 - $6.24 $654,089 - $983,498
-157,612 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$4.54 - $7.17 $69,993 - $110,539
-15,417 Reduced 8.91%
157,612 $730,000
Q1 2021

May 17, 2021
BUY
$4.57 - $7.18 $790,742 - $1.24 Million
173,029 New
173,029 $1.03 Million

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email